{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T12:19:37Z","timestamp":1700396377719},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,7,18]],"date-time":"2001-07-18T00:00:00Z","timestamp":995414400000},"content-version":"vor","delay-in-days":78,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2001,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Growth in health information systems presents opportunities to enhance postmarketing safety surveillance of medical products. Spontaneous suspected side effect reports provide the foundation, but we need to \u2018proactively\u2019 improve their quality and our strategies to seek signals. In our more familiar \u2018reactive\u2019 mode, we examine hypotheses from inquiries or publicity. Such responsive evaluations remain essential but may miss latent information on unsuspected risks. Efficient techniques to disclose hidden clusters and associations may emerge through adaptation of approaches from industrial quality control and other disciplines. Data\u2010driven techniques like exploratory analysis, control charts, and time series modeling may help in sifting through accumulated data and in screening consecutive submissions to discern hints of new product hazards or of more specific understanding about previously identified potential side effects. We also need to cultivate non\u2010spontaneous data for hypothesis generation as well as testing, the systematic epidemiologic evaluation of questions and concerns. This hypothesis testing function will assume greater importance if proactive safety surveillance methods yield larger numbers of putatively positive findings. Whether from spontaneous reports or other sources, signals that could have arisen by chance alone usually represent only clues to potential hazards until or unless they can be verified through independent studies. Copyright \u00a9 2001 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/pds.587","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T21:49:13Z","timestamp":1030312153000},"page":"191-196","source":"Crossref","is-referenced-by-count":11,"title":["Proactive safety surveillance"],"prefix":"10.1002","volume":"10","author":[{"given":"Edward A.","family":"Bortnichak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel E.","family":"Salive","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh H.","family":"Tilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,7,18]]},"reference":[{"key":"e_1_2_1_2_2","volume-title":"Webster's Ninth New Collegiate Dictionary","year":"1990"},{"key":"e_1_2_1_3_2","volume-title":"Principles of Drug Development in Transplantation and Autoimmunity","author":"Wise RP","year":"1996"},{"key":"e_1_2_1_4_2","volume-title":"International Reporting of Periodic Drug\u2010Safety Update Summaries, Final Report of CIOMS Working Group II","year":"1992"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1557(199910\/11)8:6<457::AID-PDS452>3.0.CO;2-S"},{"key":"e_1_2_1_6_2","first-page":"577","article-title":"CDC. Intussusception among Recipients of rotavirus vaccine\u2013United States, 1998\u20101999","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_1_7_2","first-page":"000","article-title":"Precautions for proactive surveillance","volume":"10","author":"Walker AM","year":"2001","journal-title":"Pharmacoepidemiol Drug Safe"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550140068042"},{"issue":"1","key":"e_1_2_1_9_2","first-page":"S75","article-title":"Assessing the contribution of positive rechallenges in post\u2010licensure surveillance of vaccine safety (Abstract)","volume":"5","author":"Niu MT","year":"1996","journal-title":"Pharmacoepidemiol Drug Safe"},{"issue":"1","key":"e_1_2_1_10_2","first-page":"S49","article-title":"Risk factor confirmation using case\u2013control analysis of spontaneous reports (Abstract)","volume":"4","author":"Hauben M","year":"1995","journal-title":"Pharmacoepidemiol Drug Safe"},{"issue":"1","key":"e_1_2_1_11_2","first-page":"S66","article-title":"The case\/non\u2010case design to generate and assess alerts from pharmacovigilance case\u2010report databases (Abstract)","volume":"4","author":"Moore ND","year":"1995","journal-title":"Pharmacoepidemiol Drug Safe"},{"issue":"1","key":"e_1_2_1_12_2","first-page":"S69","article-title":"Hypothesis testing using spontaneous reports as a source for case\u2013control studies (Abstract)","volume":"4","author":"Martinez C","year":"1995","journal-title":"Pharmacoepidemiol Drug Safe"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.2307\/2686093"},{"issue":"2","key":"e_1_2_1_14_2","first-page":"S99","article-title":"Identifying and quantifying signals automatically","volume":"7","author":"Bate A","year":"1998","journal-title":"Pharmacoepidemiol Drug Safe"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050466"},{"issue":"1","key":"e_1_2_1_16_2","first-page":"S37","article-title":"A symposium on computer\u2010assisted safety signal identification","volume":"9","author":"Bortnichak E","year":"2000","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1557(199709\/10)6:5<370::AID-PDS311>3.0.CO;2-V"},{"key":"e_1_2_1_18_2","article-title":"Automated safety signal detection at FDA's Center for Drug Evaluation and Research","author":"Bright R","journal-title":"Pharmacoepidemiol Drug Safe"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.571"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.99.6.765"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199711133372012"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.4065\/70.7.628"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.587","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.587","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T15:46:35Z","timestamp":1700322395000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1002\/pds.587"],"URL":"https:\/\/doi.org\/10.1002\/pds.587","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}